.jpg)
Health Tech: Cash for holistic health – Axios
Health Tech: Cash for holistic health Axios Read Original Article: Health Tech: Cash for holistic health…
Category: Life Sciences
STAT+: From a small town in Wales, a scientific sleuth has shaken Dana-Farber — and elevated the issue of research integrity
PONTYPRIDD, Wales — The blog post that has shaken the leadership of Boston’s Dana-Farber Cancer…
STAT+: Merck, Johnson & Johnson CEOs agree to testify in Congress on high drug prices, avoiding Bernie Sanders’ subpoena
WASHINGTON — Merck CEO Robert Davis and Johnson and Johnson CEO Joaquin Duato have agreed…
STAT+: Vaccines save lives and generate profits. Why is investment lagging?
Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of…
Eli Lilly overtakes Tesla in market value
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about Sanders jabbing Merck’s CEO, fixing drug shortages, and more
And so, another working week will soon draw to a close. Not a moment too…
A call to add sexual orientation and gender identity data to electronic health records
There are more openly LGBTQ+ people in the U.S. than ever, but little is known…
Opinion: Congress must pass the child tax credit deal to support kids’ health
When I enter, “what is pediatrics?” into an image search engine, I get back dozens…
STAT+: Democrats urge government to rein in Medicare Advantage overpayments and denials
The Biden administration is about to set the ground rules for next year’s Medicare Advantage…
The Employer Public Option: A Tool for Improving Affordability via Alternative Health Coverage – Center For American Progress
The Employer Public Option: A Tool for Improving Affordability via Alternative Health Coverage Center For American…
STAT+: FTC sues to block a proposed hospital deal in North Carolina
The federal government is suing to block a proposed hospital deal in North Carolina, alleging…
STAT+: Generic group sues Illinois over a price-gouging law with ‘draconian regulations’
The trade group for generic drug companies in the U.S. has filed a lawsuit alleging…
Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says
WASHINGTON — Sen. Bernie Sanders on Thursday jabbed the CEO of Merck for telling congressional…
Listen: The plight of the VC, Gilead’s latest setback, & more M&A
Are venture capitalists OK? Are bolt-ons good for business? And when is it safe to…
Zyn scrutiny from Sen. Chuck Schumer prompts an unlikely culture war
Senate Majority Leader Chuck Schumer (D-N.Y.) wants the federal government to investigate Zyn nicotine pouches….
STAT+: CVS wants to become a medical powerhouse. Will long lines and understaffing hold it back?
CVS Health is perhaps best known for two things. First, there are the comically long…
.jpg)
Bernie Sanders’ showdown with pharma CEOs is coming to a head
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Humana projects a tough road for Medicare Advantage, sinking its stock
Humana’s Medicare Advantage business is faring even worse than the company let on last week,…
STAT+: Early detection of pancreatic cancer could get a boost from AI that identifies people at higher risk
Limor Appelbaum has seen too many patients whose first sign of a fatal illness came…
HPV vaccine study finds zero cases of cervical cancer among women vaccinated before age 14
A historic new study out of Scotland shows the real-world impact of vaccines against the…
STAT+: Key Senate panel considers Medicare bonuses for hospitals that prevent drug shortages
WASHINGTON — A key Senate committee is proposing that Medicare pay bonuses to hospitals that…
Two genomics powerhouses team up to expand infectious disease surveillance
LONDON — Two research centers that have been at the forefront of following the evolution…
Another step toward new drugs for Parkinson’s
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about fake Ozempic, the FTC policing pharma, and more
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are…
STAT+: As biotech VCs struggle to raise money, some debate whether the worst is over
Over the last year or two, something curious has started occurring in the conference rooms…
Opinion: Other states should follow New Jersey’s lead on prior authorization reform
Imagine this scene: You are a cancer patient already navigating fear and uncertainty around your…
STAT+: What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s surprising rise
Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura…
Transgender women’s higher risk for HIV is influenced by discrimination, CDC finds
Transgender women, in particular those belonging to marginalized racial and ethnic groups, have disproportionately high…
STAT+: A PBM in Africa flips the industry’s script in a bid to make people healthier
WASHINGTON — For an app that helps pharmacies in Africa manage their medicines, the term…
‘The response defies belief’: Year of inaction leaves children at risk from bad cancer drugs
A year after an investigation revealed widespread use of a substandard cancer drug, the World…
Health Tech: SSRI alternative – Axios
Health Tech: SSRI alternative Axios Read Original Article: Health Tech: SSRI alternative – Axios »
STAT+: When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’
Over the past two years, the U.S. Federal Trade Commission has attempted to crack down…
STAT+: Osteoarthritis might be linked to protein known for its role in Alzheimer’s, study says
A kind of protein implicated in Alzheimer’s disease might also contribute to the breakdown of…
New chronic Covid study offers insight into which immunocompromised patients are most at risk
You’ve heard of long Covid, a condition in which the acute infection subsides but troubling…
STAT+: Pharmalittle: We’re reading about Lilly’s gene therapy for hearing, Shkreli’s life-long ban, and more
Good morning, everyone, and how are you today? We are doing just fine, thank you….
Lilly’s gene therapy restores hearing in an 11-year-old, paving way for more treatment
Want to stay on top of the science and politics driving biotech today? Sign up to get…
As NIH grant runs out, Dog Aging Project founders look to raise up to $50 million
The Dog Aging Project, which researchers say could yield promising leads for human longevity research,…
STAT+: FDA OKs — but doesn’t require — a non-cancer-causing chemical for sterilizing devices
The chemical used to sterilize half of all medical devices in the United States is…
Opinion: Defunding liberal arts is dangerous for health care
If you want an argument in favor of teaching the humanities, I suggest you ask…
Opinion: After 20 years in rehabilitation research, my young daughter’s traumatic brain injury transformed my mind and my career
In the spring of 2020, my almost 4-year-old daughter Livie sustained a severe traumatic brain…
STAT+: A for-profit health system’s financial issues could plunge overburdened hospitals into crisis
Steward Health Care, a for-profit health system that serves thousands of patients in Eastern Massachusetts,…
Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about FDA warnings on CAR-T drugs, a Sanofi deal, and more
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
White House pharmacy under the microscope
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Mammograms are less effective for women with dense breast tissue. Medical experts disagree on what to do about it
Millions of American women over age 40 receive regular mammograms to screen for breast cancer….
STAT+: Pharma’s attack on Medicare drug price negotiation might benefit Biden
WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program…
The White House has a pharmacy — and it’s been a mess, a new investigation found
There’s a pharmacy in the White House — or, at least, there’s a sign that…
Opinion: It’s time to remove skin color from the Apgar Score for newborns
In medicine, inertia can be a strangely powerful force, but Virginia Apgar never succumbed to…
Abortion funds run short of money as demand soars and donations fall
The head of the Abortion Fund of Ohio had a sinking feeling as she looked…
STAT+: Sanofi scoops up U.S. biotech Inhibrx for up to $2.2 billion as it seeks to bolster pipeline
LONDON — In a bid to expand its pipeline of inflammation-targeting drugs, Sanofi said Tuesday…